Holen Sie sich die Stockscreener-App
238.67
0.60%
-1.43
Handel nachbörslich:
238.33
-0.34
-0.14%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt JNJ?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$240.10
Offen:
$239.935
24-Stunden-Volumen:
6.42M
Relative Volume:
0.74
Marktkapitalisierung:
$574.86B
Einnahmen:
$94.19B
Nettoeinkommen (Verlust:
$26.80B
KGV:
21.61
EPS:
11.0458
Netto-Cashflow:
$19.70B
1W Leistung:
-1.09%
1M Leistung:
-1.18%
6M Leistung:
+24.85%
1J Leistung:
+55.36%
1-Tages-Spanne:
$236.75
$240.42
1-Wochen-Bereich:
$233.25
$244.20
52-Wochen-Spanne:
$146.12
$251.71
Johnson Johnson Stock (JNJ) Company Profile
Firmenname
Johnson Johnson
Sektor
Telefon
732-524-2455
Adresse
ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ
Compare JNJ vs LLY, ABBV, AZN, MRK
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
JNJ
Johnson Johnson
|
238.67 | 578.31B | 94.19B | 26.80B | 19.70B | 11.05 |
LLY
Lilly Eli Co
|
905.03 | 824.12B | 65.18B | 20.64B | 5.96B | 22.59 |
ABBV
Abbvie Inc
|
208.42 | 371.90B | 61.16B | 4.19B | 17.82B | 2.3614 |
AZN
Astrazeneca Plc
|
201.21 | 316.96B | 58.80B | 10.24B | 8.98B | 3.2788 |
MRK
Merck Co Inc
|
117.90 | 296.29B | 64.93B | 18.26B | 12.36B | 7.2751 |
Johnson Johnson Stock (JNJ) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Fortgesetzt | TD Cowen | Buy |
| 2026-01-28 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-20 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2025-10-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-09-23 | Hochstufung | Guggenheim | Neutral → Buy |
| 2025-07-23 | Hochstufung | Erste Group | Hold → Buy |
| 2025-05-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-07-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2024-05-30 | Fortgesetzt | Goldman | Neutral |
| 2024-04-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2023-12-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-12-01 | Hochstufung | UBS | Neutral → Buy |
| 2023-10-05 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Fortgesetzt | Citigroup | Buy |
| 2023-03-29 | Eingeleitet | UBS | Neutral |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-11-18 | Eingeleitet | Credit Suisse | Neutral |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-14 | Bestätigt | BofA Securities | Neutral |
| 2022-06-22 | Eingeleitet | Daiwa Securities | Outperform |
| 2022-05-23 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-16 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-02 | Fortgesetzt | BofA Securities | Neutral |
| 2021-12-17 | Eingeleitet | Goldman | Neutral |
| 2021-12-15 | Bestätigt | Citigroup | Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-05-28 | Fortgesetzt | Morgan Stanley | Overweight |
| 2020-04-28 | Herabstufung | UBS | Buy → Neutral |
| 2020-04-22 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2019-12-19 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2019-12-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2019-11-20 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-16 | Hochstufung | Atlantic Equities | Underweight → Neutral |
| 2019-10-11 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2019-07-12 | Fortgesetzt | Credit Suisse | Outperform |
| 2019-05-28 | Eingeleitet | Goldman | Buy |
| 2019-01-23 | Bestätigt | Barclays | Equal Weight |
| 2018-07-12 | Hochstufung | Goldman | Sell → Neutral |
| 2018-06-27 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-04-23 | Bestätigt | Citigroup | Neutral |
| 2018-04-18 | Bestätigt | Stifel | Hold |
| 2018-01-24 | Bestätigt | Stifel | Hold |
| 2018-01-12 | Bestätigt | Wells Fargo | Outperform |
| 2018-01-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-10-18 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-10-18 | Bestätigt | Stifel | Hold |
Alle ansehen
Johnson Johnson Aktie (JNJ) Neueste Nachrichten
Chicago City Council fails to override Mayor Brandon Johnson veto of minimum wage increase freeze for tipped workers - ABC7 Chicago
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? - Yahoo Finance
Trey Johnson hired as Jackson State basketball coach replacing Mo Williams - The Clarion-Ledger
Armstrong, Johnson earn top LABC Awards - McNeese State University Athletics
'Facts are indisputable': House Speaker Johnson backs expelling Cherfilus-McCormick from Congress - WUSF
Obituary for Ronald Allen Johnson - Haggard Hirschy & Zelt Funeral Home
Auburn College of Education EAGLES student Jamari “JJ” Johnson soars into future, anchored with confidence, community and the Auburn spirit - Auburn University
WNBA draft 2026: Best picks, sleepers and biggest takeaways - ESPN
J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer - BioSpace
Man jailed after viewing child sex abuse on a train – London - British Transport Police
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results - Investing.com
‘Long time coming’ – Johnson-Holmes proud to reach 100 - Western Force
S Lonnie Johnson Jr.Apr. 14 | Press Conference - Miami Dolphins
Johnson outlines stronger protections for domestic violence survivors - Illinois Senate Democratic Caucus
CDOT warns travelers of extended eastbound closure on I-70 near Eisenhower-Johnson Memorial Tunnel - Colorado Department of Transportation (.gov)
Obituary | David Okayama Johnson of Russellville, South Carolina - Dial-Murray Funeral Home, Inc.
What Johnson & Johnson Earnings Signal for Healthcare ETFs - ETF Database
College of Arts and Humanities announces 2026 student awards - Clemson News
Obituary for Richard Dean Carlson - Harvey Anderson & Johnson Funeral Home
Johnson & Johnson Earnings: Firm Sees New Launches, Long-Term Guidance Looks Optimistic - Morningstar
Phils call up Shugart for bullpen help; Johnson optioned - MLB.com
Morgan Lee Johnson Obituary April 9, 2026 - Moore Funeral Home | Tulsa, OK
Johnson Earns Bid to Portsmouth Invitational - Kansas State University Athletics
Johnson & Johnson Q2 Earnings Review: Why You Should Be Buying The Stock Today (NYSE:JNJ) - Seeking Alpha
Raven Johnson Explains Why She's Most Excited to Team Up With Caitlin Clark on Fever - Sports Illustrated
Johnson Named Both ACC Pitcher of the Week and NFCA Top Performer – Softball - Georgia Tech Athletics
Johnson and Johnson Raises Dividend for 64th Consecutive Year - Yahoo Finance
Johnson & Johnson Q1 2026 Earnings Call Summary - Yahoo Finance
Carson Johnson Named to CSC Academic All-America Third Team - University of Denver Athletics
Jim Cramer on Johnson & Johnson: “If It Gets Blasted, Try to Get Some” - Yahoo Finance
J&J leans on Tremfya, cancer drugs to overcome Stelara losses - BioPharma Dive
Why Caitlin Clark Might Want to Apologize to Raven Johnson, Who the Fever Took No. 10 in the WNBA Draft - Sports Illustrated
Nige and Zia set out plan to send ‘Boriswave’ traitors to the gulag | John Crace - The Guardian
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1% - BioSpace
Obituary for Cynthia "Cindy" C. Johnson - Woodland Hills Funeral Home
Earvin ‘Magic’ Johnson brings 10,000-megawatt smile and inspiration to UIC Chair Chats - UIC today
Marine duo secures first sniper competition victory in 17 years - Stars and Stripes
Cramer's Mad Dash: Johnson & Johnson - CNBC
Johnson & Johnson (JNJ) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
J&J's first-quarter profit beats estimates even as Stelara sales disappoint - Reuters
Watch CNBC's full interview with Johnson & Johnson CFO Joseph Wolk - CNBC
Johnson & Johnson CFO Wolk on Q1 earnings results - CNBC
J&J tops first-quarter profit estimates even as Stelara sales plunge - CNBC
What you need to know about Johnson & Johnson’s first-quarter 2026 earnings report - Johnson & Johnson
J&J’s First-Quarter Sales Grow on Cancer-Drug Strength - WSJ
Dallas primary election voting confusion prompts congressional talk on voter suppression - KERA News
How Johnson and Jeffries handled their ethics problems - Punchbowl News
Obituary | Kipton Lyle Johnson - Miller Funeral Home & On-Site Crematory
H. F. Johnson Gallery of Art Presents: ‘Senior Exhibitions’ • Events Calendar - Carthage College
Valkyries GM: Agreed to Storm trade before Flau'jae Johnson selection - ESPN
WNBA draft: Mystics, Storm, Lynx and Wings get top marks - ESPN
Finanzdaten der Johnson Johnson-Aktie (JNJ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):